CD30 +
About
Biomarker type: Protein expression
Marker: CD30
Unit: status
Equality: =
Value: Positive
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | CD30 + | Anaplastic Large Cell Lymphoma | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone | |
| FDA (2) | CD30 + | Anaplastic Large Cell Lymphoma | Brentuximab vedotin | |
| HC (1) | CD30 + | Mycosis Fungoides | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone | |
| HC (1) | CD30 + | Angioimmunoblastic T-Cell Lymphoma | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone | |
| HC (1) | CD30 + | Peripheral T-Cell lymphoma, NOS | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone |